Oncogene Protein v-akt
This graph shows the total number of publications written about "Oncogene Protein v-akt" by people in the URMC Research Network by year, and whether "Oncogene Protein v-akt" was a major or minor topic of these publication.
Below are the most recent publications written about "Oncogene Protein v-akt" by people in Profiles.
-
Mi Z, Rogers DA, Mirnics ZK, Schor NF. p75NTR-dependent modulation of cellular handling of reactive oxygen species. J Neurochem. 2009 Jul; 110(1):295-306.
-
Wolpin BM, Hezel AF, Abrams T, Blaszkowsky LS, Meyerhardt JA, Chan JA, Enzinger PC, Allen B, Clark JW, Ryan DP, Fuchs CS. Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol. 2009 Jan 10; 27(2):193-8.
-
Sen A, Lv L, Bello N, Ireland JJ, Smith GW. Cocaine- and amphetamine-regulated transcript accelerates termination of follicle-stimulating hormone-induced extracellularly regulated kinase 1/2 and Akt activation by regulating the expression and degradation of specific mitogen-activated protein kinase phosphatases in bovine granulosa cells. Mol Endocrinol. 2008 Dec; 22(12):2655-76.
-
Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008 Aug; 149(8):4183-92.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
